Literature DB >> 30401716

EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma.

Zhenyi An1, Christiane B Knobbe-Thomsen2, Xiaohua Wan1, Qi Wen Fan1, Guido Reifenberger2, William A Weiss3,4,5.   

Abstract

: Amplification of the EGFR gene and its truncation mutant EGFRvIII are hallmarks of glioblastoma. Although coexpression of EGFR and EGFRvIII confers a growth advantage, how EGFR and EGFRvIII influence the tumor microenvironment remains incompletely understood. Here, we show that EGFR and EGFRvIII cooperate to induce macrophage infiltration via upregulation of the chemokine CCL2. EGFRvIII was significantly enriched in glioblastoma patient samples with high CCL2, and knockout of CCL2 in tumors coexpressing EGFR and EGFRvIII led to decreased infiltration of macrophages. KRAS was a critical signaling intermediate for EGFR- and EGFRvIII-induced expression of CCL2. Our results illustrate how EGFR and EGFRvIII direct the microenvironment in glioblastoma. SIGNIFICANCE: Full-length EGFR and truncated EGFRvIII work through KRAS to upregulate the chemokine CCL2 and drive macrophage infiltration in glioblastoma. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30401716      PMCID: PMC6295222          DOI: 10.1158/0008-5472.CAN-17-3551

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

Review 1.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

2.  Origin of the U87MG glioma cell line: Good news and bad news.

Authors:  Marie Allen; Mia Bjerke; Hanna Edlund; Sven Nelander; Bengt Westermark
Journal:  Sci Transl Med       Date:  2016-08-31       Impact factor: 17.956

3.  Establishment, maintenance and in vitro and in vivo applications of primary human glioblastoma multiforme (GBM) xenograft models for translational biology studies and drug discovery.

Authors:  Brett L Carlson; Jenny L Pokorny; Mark A Schroeder; Jann N Sarkaria
Journal:  Curr Protoc Pharmacol       Date:  2011-03

4.  Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts.

Authors:  Hannah Johnson; Amanda M Del Rosario; Bryan D Bryson; Mark A Schroeder; Jann N Sarkaria; Forest M White
Journal:  Mol Cell Proteomics       Date:  2012-09-10       Impact factor: 5.911

Review 5.  CD90 a potential cancer stem cell marker and a therapeutic target.

Authors:  Muhammad Vaseem Shaikh; Manika Kala; Manish Nivsarkar
Journal:  Cancer Biomark       Date:  2016       Impact factor: 4.388

6.  Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas.

Authors:  Michael Platten; Alexandra Kretz; Ulrike Naumann; Steffen Aulwurm; Kensuke Egashira; Stefan Isenmann; Michael Weller
Journal:  Ann Neurol       Date:  2003-09       Impact factor: 10.422

Review 7.  The Impact of the Tumor Microenvironment on the Properties of Glioma Stem-Like Cells.

Authors:  Alessandra Audia; Siobhan Conroy; Rainer Glass; Krishna P L Bhat
Journal:  Front Oncol       Date:  2017-07-10       Impact factor: 6.244

Review 8.  Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies.

Authors:  Zhenyi An; Ozlem Aksoy; Tina Zheng; Qi-Wen Fan; William A Weiss
Journal:  Oncogene       Date:  2018-01-11       Impact factor: 9.867

Review 9.  Extracellular Vesicles As Modulators of Tumor Microenvironment and Disease Progression in Glioma.

Authors:  Abir Mondal; Divya Kumari Singh; Suchismita Panda; Anjali Shiras
Journal:  Front Oncol       Date:  2017-07-05       Impact factor: 6.244

Review 10.  The M1 and M2 paradigm of macrophage activation: time for reassessment.

Authors:  Fernando O Martinez; Siamon Gordon
Journal:  F1000Prime Rep       Date:  2014-03-03
View more
  21 in total

1.  In Vitro Assay to Study Tumor-macrophage Interaction.

Authors:  Zhenyi An; William A Weiss
Journal:  J Vis Exp       Date:  2019-08-01       Impact factor: 1.355

2.  'Characterization of monoclonal antibodies generated to the 287-302 amino acid loop of the human epidermal growth factor receptor'.

Authors:  Eric Chun Hei Ho; Antonella Antignani; Robert Sarnovsky; David FitzGerald
Journal:  Antib Ther       Date:  2019-11-29

Review 3.  Phenotypic plasticity of myeloid cells in glioblastoma development, progression, and therapeutics.

Authors:  Zengpanpan Ye; Xiaolin Ai; Linjie Zhao; Fan Fei; Ping Wang; Shengtao Zhou
Journal:  Oncogene       Date:  2021-09-23       Impact factor: 9.867

Review 4.  Co-dependencies in the tumor immune microenvironment.

Authors:  Peiwen Chen; Prasenjit Dey
Journal:  Oncogene       Date:  2022-07-11       Impact factor: 8.756

5.  Crosstalk between β-Catenin and CCL2 Drives Migration of Monocytes towards Glioblastoma Cells.

Authors:  Philippe Aretz; Donata Maciaczyk; Suad Yusuf; Rüdiger V Sorg; Daniel Hänggi; Hongjia Liu; Hongde Liu; Tikam Chand Dakal; Amit Sharma; Ramakrishna Bethanabatla; Silke Neumann; Jarek Maciaczyk
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

Review 6.  Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implications.

Authors:  Jun Wei; Peiwen Chen; Pravesh Gupta; Martina Ott; Daniel Zamler; Cynthia Kassab; Krishna P Bhat; Michael A Curran; John F de Groot; Amy B Heimberger
Journal:  Neuro Oncol       Date:  2020-02-20       Impact factor: 12.300

Review 7.  Context-Dependent Glioblastoma-Macrophage/Microglia Symbiosis and Associated Mechanisms.

Authors:  Wenjing Xuan; Maciej S Lesniak; Charles David James; Amy B Heimberger; Peiwen Chen
Journal:  Trends Immunol       Date:  2021-03-01       Impact factor: 16.687

8.  Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome.

Authors:  María González-Tablas Pimenta; Álvaro Otero; Daniel Angel Arandia Guzman; Daniel Pascual-Argente; Laura Ruíz Martín; Pablo Sousa-Casasnovas; Andoni García-Martin; Juan Carlos Roa Montes de Oca; Javier Villaseñor-Ledezma; Luis Torres Carretero; Maria Almeida; Javie Ortiz; Adelaida Nieto; Alberto Orfao; María Dolores Tabernero
Journal:  Brain Pathol       Date:  2021-02-13       Impact factor: 6.508

9.  EMP3 mediates glioblastoma-associated macrophage infiltration to drive T cell exclusion.

Authors:  Qun Chen; Jing Jin; Xin Huang; Fan Wu; Hongguang Huang; Renya Zhan
Journal:  J Exp Clin Cancer Res       Date:  2021-05-08

Review 10.  Macrophages/Microglia in the Glioblastoma Tumor Microenvironment.

Authors:  Jun Ma; Clark C Chen; Ming Li
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.